Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05704257 · ClinicalTrials.gov registry record · NA

Fetal Repair of Complex Gastroschisis: A Safety and Feasibility Trial

A NA study of Gastroschisis, sponsored by Baylor College of Medicine.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT05704257: Recruiting NA study of Gastroschisis, sponsored by Baylor College of Medicine.

NCT05704257 is a NA study of Gastroschisis that is actively recruiting participants, run by Baylor College of Medicine. The registered enrollment target is 10 participants, below the 94-participant average among 4 other Gastroschisis trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05704257, a NA study of Gastroschisis, is actively recruiting participants, sponsored by Baylor College of Medicine.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to evaluate the safety and feasibility of fetal repair of complex gastroschisis (GS) via a fetoscopic surgical approach by assessing maternal, fetal, neonatal, and infant outcomes in a cohort of 10 patients. The hypothesis is that in utero repair of GS will reduce postnatal mortality and morbidity in complex GS infants with minimal maternal and fetal risk.

Primary Outcome

Success of primary skin closure after complete bowel reduction.

Conditions Studied

Interventions

  • DEVICE fetoscopy

Study Locations (1)

Texas

  • Texas Children's Hospital - Houston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2023-10-20
Est. Completion 2029-12
Phase NA
Baylor College of Medicine

616 total trials

What NCT05704257 shows while recruiting

NCT05704257 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 94-participant average among 4 other Gastroschisis trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Gastroschisis appearing as the primary indexed condition, and to 1 intervention - of which fetoscopy is the first listed.

NCT05704257 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT05704257 about?

NCT05704257 is a clinical study titled "Fetal Repair of Complex Gastroschisis: A Safety and Feasibility Trial". The goal of this clinical trial is to evaluate the safety and feasibility of fetal repair of complex gastroschisis (GS) via a fetoscopic surgical approach by assessing maternal, fetal, neonatal, and infant outcomes in a cohort of 10 patients. The hypothesis is that in utero repair of GS will reduce ...

What is the current status of trial NCT05704257?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-10-20. Estimated completion is 2029-12.

What conditions does trial NCT05704257 study?

This clinical trial studies the following conditions: Gastroschisis.

What interventions are being tested in trial NCT05704257?

The interventions under investigation include: fetoscopy (DEVICE).

Who is sponsoring clinical trial NCT05704257?

This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05704257 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Gastroschisis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05704257, the US trial registry maintained by the National Library of Medicine. NCT05704257 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.